Skip to main content
Neogen Chemicals Limited logo

Neogen Chemicals Limited — Investor Relations & Filings

Ticker · NEOGEN ISIN · INE136S01016 LEI · 335800PFY9B77Z2GOK22 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2026-03-07 Capital/Financing Update
Country IN India
Listing BSE.NS NEOGEN

About Neogen Chemicals Limited

https://neogenchem.com/

Neogen Chemicals Limited specializes in the development and large-scale manufacturing of bromine-based and lithium-based specialty chemicals. The product portfolio includes a diverse range of bromine derivatives, lithium salts, Grignard reagents, and advanced intermediates. These products serve critical roles in pharmaceutical, agrochemical, and engineering applications. The company has expanded its operations into the energy storage market, focusing on the production of electrolytes and lithium salts for lithium-ion batteries. With a strong emphasis on research and development, the firm provides custom synthesis and contract manufacturing services to global innovators. Manufacturing capabilities are supported by multi-product facilities designed to meet stringent quality standards for complex chemical processes and high-purity requirements.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the outcome of a Board Meeting held on March 7, 2026. The key content includes approval of a preferential issue of equity shares, details of the issuance, and the convening of an Extraordinary General Meeting (EGM) to seek shareholder approval for the preferential issue. It also includes detailed disclosure pursuant to SEBI regulations about the preferential issue, including number of shares, pricing, allottee details, lock-in requirements, and record dates for voting. The document is regulatory in nature, announcing a capital raising event and related shareholder meeting, but it is not a full financial report or earnings release. It is not a proxy statement or voting results announcement, but rather an update on capital/financing activity and meeting arrangements. The document length is over 10,000 characters and contains substantive details about the capital issuance. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2026-03-07 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-03-04 English
Board Meeting — Fund Raising/Other business matters
Capital/Financing Update Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming Board of Directors meeting scheduled to consider and approve a proposal for raising funds through a preferential issue of equity shares. It references compliance with SEBI regulations and the closure of the trading window for insiders. The document does not contain any financial data, results, or detailed report content but is an announcement of a future board meeting and potential capital raising activity. The length is short (3091 characters), and it serves as an intimation rather than a report or detailed filing. Therefore, it fits best under Capital/Financing Update (CAP) as it informs about planned financing activities.
2026-03-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about the rescheduling of an investor/analyst meeting (Investec India Promoter & Founder Conference 2026). It references Regulation 30 of SEBI Listing Obligations, which pertains to disclosure of material events and information. The content focuses on informing about the date and mode of the meeting and mentions that the discussion will cover business overview, financial performance, and outlook. The document does not contain any actual financial statements, detailed financial data, or report content. It is a short notice (2304 characters) and serves as an announcement of an investor presentation event rather than the presentation itself or a financial report. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to a detailed presentation for investors focusing on financials, strategy, and market position, even though the actual presentation is not included here, the notice is about the meeting where such presentation will occur. However, since this is only an intimation of the meeting and not the presentation material itself, and given the short length and nature of the document, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory disclosure about an event rather than the presentation or report itself. Hence, the best classification is Regulatory Filings (RNS).
2026-03-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q3 FY26 earnings conference call of Neogen Chemicals Limited held on February 12, 2026. It includes management's opening remarks, financial performance overview, strategic updates, and a Q&A session with analysts. The content focuses on quarterly financial results, operational updates, and future outlook, which are typical characteristics of an earnings call transcript. There is no indication that this is a brief earnings release or a presentation slide deck, but a full transcript of the call. Therefore, the document fits the category of a Call Transcript (CT).
2026-02-18 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an update addressed to stock exchanges regarding a fire incident at the company's facility. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 30 and 51, which pertain to disclosure of material events. The content details insurance claims received, damage assessment, and steps taken to restore operations. There are no financial statements or comprehensive financial data presented, nor is this a full report. The document is a regulatory announcement updating the market on a material event affecting the company. It is not an annual or interim report, earnings release, or management discussion. The document is a regulatory filing under SEBI rules providing material event disclosure.
2026-02-12 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.